Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: Incidence, Analysis and Follow-Up in 1236

Rodrigo Villagrán1, Gabriela Smith2, Walter Rodriguez3

  • 1Bariatric Surgery Department, Bupa Antofagasta Clinic, Matta 1868, 2nd floor, Antofagasta, Chile. villagranrodrigo@gmail.com.

Obesity Surgery
|April 16, 2016
PubMed
Abstract

Insights

Portomesenteric vein thrombosis (PMVT) is a rare complication after laparoscopic sleeve gastrectomy (LSG). Early diagnosis and anticoagulant therapy are crucial for managing this condition and preventing severe outcomes.

Area of Science:

  • Gastroenterology
  • Vascular Surgery
  • Bariatric Surgery

Background:

  • Portomesenteric vein thrombosis (PMVT) is a rare but serious complication following laparoscopic bariatric surgery.
  • Laparoscopic sleeve gastrectomy (LSG) is an increasingly common bariatric procedure.
  • Understanding PMVT after LSG is crucial for patient outcomes.

Purpose of the Study:

  • To determine the incidence of PMVT after LSG.
  • To describe the clinical features, management, and outcomes of PMVT in LSG patients.
  • To evaluate midterm follow-up findings in patients who developed PMVT post-LSG.

Main Methods:

  • Retrospective and descriptive study design.
  • Inclusion of patients who underwent LSG between November 2009 and July 2015 and subsequently developed PMVT.
  • Analysis of patient demographics, risk factors, surgical details, treatment, and follow-up data.

Main Results:

  • A total of 1236 patients underwent LSG, with 5 (0.4%) developing PMVT.
  • Smoking was identified as a predominant risk factor.
  • All patients received anticoagulant therapy, with two showing complete recanalization and one developing portal cavernomatosis.

Conclusions:

  • PMVT is a rare but significant complication of LSG, with smoking as a key risk factor.
  • Prompt diagnosis and anticoagulant treatment are vital to reduce complications like intestinal infarction and mortality.
  • Long-term follow-up is essential to assess the full impact of PMVT on patient health.